4-Pyridone-3-carboxamide-1-β-d-ribonucleoside Triphosphate (4PyTP), a Novel NAD+ Metabolite Accumulating in Erythrocytes of Uremic Children: A Biomarker for a Toxic NAD+ Analogue in Other Tissues?
Open Access
- 6 June 2011
- Vol. 3 (6), 520-537
- https://doi.org/10.3390/toxins3060520
Abstract
We have identified a novel nucleotide, 4-pyridone 3/5-carboxamide ribonucleoside triphosphate (4PyTP), which accumulates in human erythrocytes during renal failure. Using plasma and erythrocyte extracts obtained from children with chronic renal failure we show that the concentration of 4PyTP is increased, as well as other soluble NAD+ metabolites (nicotinamide, N1-methylnicotinamide and 4Py-riboside) and the major nicotinamide metabolite N1-methyl-2-pyridone-5-carboxamide (2PY), with increasing degrees of renal failure. We noted that 2PY concentration was highest in the plasma of haemodialysis patients, while 4PyTP was highest in erythrocytes of children undergoing peritoneal dialysis: its concentration correlated closely with 4Py-riboside, an authentic precursor of 4PyTP, in the plasma. In the dialysis patients, GTP concentration was elevated: similar accumulation was noted previously, as a paradoxical effect in erythrocytes during treatment with immunosuppressants such as ribavirin and mycophenolate mofetil, which deplete GTP through inhibition of IMP dehydrogenase in nucleated cells such as lymphocytes. We predict that 4Py-riboside and 4Py-nucleotides bind to this enzyme and alter its activity. The enzymes that regenerate NAD+ from nicotinamide riboside also convert the drugs tiazofurin and benzamide riboside into NAD+ analogues that inhibit IMP dehydrogenase more effectively than the related ribosides: we therefore propose that the accumulation of 4PyTP in erythrocytes during renal failure is a marker for the accumulation of a related toxic NAD+ analogue that inhibits IMP dehydrogenase in other cells.Keywords
This publication has 61 references indexed in Scilit:
- The Novel Nucleotide 4KNTP, in High Concentrations in Erythrocytes of Renal Failure Children: a Comparison with Accumulation of Other Putative Precursors in the PlasmaNucleosides, Nucleotides and Nucleic Acids, 2006
- Mycophenolate mofetil, an inhibitor of inosine monophosphate dehydrogenase, causes a paradoxical elevation of GTP in erythrocytes of renal transplant patientsClinical Science, 2004
- Conformational Changes and Stabilization of Inosine 5′-Monophosphate Dehydrogenase Associated with Ligand Binding and Inhibition by Mycophenolic AcidPublished by Elsevier BV ,1996
- Demonstration of induction of erythrocyte inosine monophosphate dehydrogenase activity in Ribavirin-treated patients using a high performance liquid chromatography linked methodClinica Chimica Acta; International Journal of Clinical Chemistry, 1995
- Biochemical and neurophysiological parameters in hemodialyzed patients with chronic renal failureClinica Chimica Acta; International Journal of Clinical Chemistry, 1989
- Isolation and Identification of 1-Ribosyl Pyridone Nucleosides from Human UrineNucleosides and Nucleotides, 1989
- Metabolism of tiazofurin by human erythrocytes and mononuclear blood cells in vitroCancer Letters, 1986
- Uptake of 2-β-d-ribofuranosylthiazole-4-carboxamide (Tiazofurin) and analogues by the facilitated transport mechanism of erythrocytesCancer Letters, 1985
- tRNA breakdown products as markers for cancerCancer, 1979
- Isolation and characterization of 1-β-D-ribofuranosylpyridin-4-one-3-carboxamide from human urineLife Sciences, 1979